Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Insurers Would Receive 25%-30% Subsidy Under GOP Plan

Executive Summary

Health plans offering prescription drugs under Medicare would receive a 25%-30% effective subsidy from the government under the Medicare drug benefit bill being developed by Rep. Thomas (R-Calif.).

You may also be interested in...



House GOP Medicare Drug Benefit Bill Could Be Marked Up June 15

A House GOP bill to provide Rx drug coverage under Medicare could be marked up as soon as June 15.

House GOP Medicare Drug Benefit Bill Could Be Marked Up June 15

A House GOP bill to provide Rx drug coverage under Medicare could be marked up as soon as June 15.

Thomas/Wyden Medicare Rx Plan Has Royalty On Federally Funded Research

Pharmaceutical companies would be required to pay a "return on investment fee" from profits on drugs that benefited from federal research funding under a Medicare drug benefit proposal outlined May 26 by Rep. Thomas (R-Calif.) and Sen. Wyden (D-Ore.).

UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel